| [1] |
Seki E，Brenner DA.Recent advancement of molecular mechanisms of liver fibrosis[J].J Hepatobiliary Pancreat Sci，2015，22（7）：512-518.
|
| [5] |
Marcellin P，Gane E，Buti M，et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B：a 5-year open-label follow-up study[J].Lancet，2013，381（9865）：468-475.
|
| [6] |
D'Ambrosio R，Aghemo A，Rumi MG，et al.A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis[J].Hepatology，2012，56（2）：532-543.
|
| [7] |
Abd ES，Fayed HM.Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat[J].J Tissue Eng Regen Med，2019，13（12）：2131-2141.
|
| [8] |
Zhao R，Li T，Zheng G，et al.Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by codelivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex[J].Biomaterials，2017，143：1-16.
|
| [9] |
Fontanay S，Grare M，Mayer J，et al.Ursolic，oleanolic and betulinic acids：antibacterial spectra and selectivity indexes[J].J Ethnopharmacol，2008，120（2）：272-276.
|
| [10] |
Zhao C，Yin S，Dong Y，et al.Autophagy-dependent EIF2AK3 activation comprom ises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells[J].Autophagy，2013，9（2）：196-207.
|
| [11] |
Liu B，Liu Y，Yang G，et al.Ursolic acid induces neural regeneration after sciatic nerve injury[J].Neural Regen Res，2013，8（27）：2510-2519.
|
| [12] |
Wan S，Luo F，Huang C，et al.Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways[J].Aging （Albany NY），2020，12（11）：10614-10632.
|
| [13] |
Care NRCU，Animals AUOL.Guide for the Care and Use of Laboratory Animals[M].Washington（DC）：National Academies Press （US），2011.
|
| [14] |
Poynard T，Bedossa P，Opolon P.Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC，METAVIR，CLINIVIR，and DOSVIRC groups[J].Lancet，1997，349（9055）：825-832.
|
| [15] |
Meng Y，Song Y，Yan Z，et al.Synthesis and in vitro cytotoxicity of novel ursolic acid derivatives [J].Molecules，2010，15（6）：4033-4040.
|
| [16] |
Gan D，Zhang W，Huang C，et al.Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway[J].J Cell Physiol，2018，233（10）：6799-6813.
|
| [17] |
He W，Shi F，Zhou ZW，et al.A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK，PI3K/Akt，and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver[J].Drug Des Devel Ther，2015，9：3989-4104.
|
| [18] |
Yu SS，Chen B，Huang CK，et al.Ursolic acid suppresses TGF-beta1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling[J].Exp Ther Med，2017，14（4）：3577-3582.
|
| [19] |
Forrester SJ，Booz GW，Sigmund CD，et al.Angiotensin ⅡSignal Transduction：An Update on Mechanisms of Physiology and Pathophysiology[J].Physiol Rev，2018，98（3）：1627-1738.
|
| [20] |
Bataller R，Gabele E，Schoonhoven R，et al.Prolonged infusion of angiotensin Ⅱinto normal rats induces stellate cell activation and proinflammatory events in liver[J].Am J Physiol Gastrointest Liver Physiol，2003，285（3）：G642-G651.
|
| [4] |
Thompson AI，Conroy KP，Henderson NC.Hepatic stellate cells：central modulators of hepatic carcinogenesis[J].BMC Gastroenterol，2015，15：63.
|
| [2] |
Lee YA，Wallace MC，Friedman SL.Pathobiology of liver fibrosis：a translational success story[J].Gut，2015，64（5）：830-841.
|
| [3] |
Zhang DY，Friedman SL.Fibrosis-dependent mechanisms of hepatocarcinogenesis[J].Hepatology，2012，56（2）：769-775.
|
| [21] |
Douillette A，Bibeau-Poirier A，Gravel SP，et al.The proinflammatory actions of angiotensin Ⅱare dependent on p65 phosphorylation by the IkappaB kinase complex[J].J Biol Chem，2006，281（19）：13275-13284.
|
| [22] |
Moreira DMS，Guimaraes TA，Feltenberger JD，et al.The role of renin-angiotensin system modulation on treatment and prevention of liver diseases[J].Peptides，2014，62：189-196.
|
